SUPT7L anticorps (AA 364-414)
Aperçu rapide pour SUPT7L anticorps (AA 364-414) (ABIN1938009)
Antigène
Voir toutes SUPT7L AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 364-414
-
Specificité
- Region between residue 364 and 414 of human Suppressor of Ty 7-like using the numbering given in entry NP_055675.1 (GeneID 9913).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: IF (1:50 - 1:500), IHC, IHC-P (1:100 - 1:500), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Colon Carcinoma. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- SUPT7L (Suppressor of Ty 7 Like (SUPT7L))
-
Autre désignation
- SPT7L / SUPT7L
-
Sujet
-
Name/Gene ID: SUPT7L
Synonyms: SUPT7L, Adenocarcinoma antigen ART1, SPT7L, STAGA complex 65 subunit gamma, STAF65(gamma), STAF65G, Suppressor of Ty 7-like, SUPT7H, STAF65gamma, STAGA complex 65 gamma subunit, KIAA0764, STAF65 -
ID gène
- 9913
-
Pathways
- Maintenance of Protein Location
Antigène
-